Meitav Investment House’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-5,750
Closed -$793K 232
2024
Q1
$793K Buy
+5,750
New +$793K 0.02% 152